Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study - Atia, O; Shavit-Brunschwig, Z; Mould, DR (Lancet Gastroenterol Hepatol, 2023)